Chronic mood disorders have been associated with a shortened telomere, a marker of increased mortality rate and aging, and impaired cellular immunity. However, treatment may confound these relationships. We examined the relationship of glucose tolerance, white blood cell count and telomere length to depression in newly diagnosed, antidepressant-naïve patients. Subjects with major depression (n = 15), and matched healthy control subjects (n = 70) underwent a two-hour oral glucose tolerance test and evaluation of blood cell count and telomere content. The depression group had significantly higher two-hour glucose concentrations and a lower lymphocyte count than control subjects (respective means (101.0 [14.3]; p < 0.01). Abnormal glucose tolerance, lymphopenia and a shortened telomere are present early in the course of depression independently of the confounding effect of antidepressant treatment, supporting the concept of major depression as an accelerated aging disease.
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Introduction
Depression will be the second contributor to the global burden of disease by 2020, according to the World health organization (WHO). The burden of depression is due not only to psychiatric disability but also to the associated comorbidity with physical diseases. The pathophysiology underlying the comorbidity remains unclear although several mechanisms have been implicated. As an etiological explanation, the association between mood disorders, cardiovascular diseases and immune disturbances has received considerable attention (Blume et al., 2011; Brown et al., 2009; Marano et al., 2009) suggesting that both systems might contribute to the increased mortality associated with mood disorders (Lippi et al., 2009 ).
Diabetes mellitus has been studied as a key factor contributing to the relationship between depression and increased cardiovascular disease. Epidemiological studies show that patients with diabetes have an increased risk of developing major depression (Egede, 2005) , an association first described in 1969 (Mueller et al., 1969) . The prevalence of depression among patients with type 2 diabetes mellitus is twice that of the general population (Nichols and Brown, 2003) , with an estimated prevalence of depression in diabetic patients of 11-15% (Anderson et al., 2001) . A meta-analysis suggested that a depressed adults have a 37% increased risk of developing type 2 diabetes (Knol et al., 2006) while another study showed a 23% increased risk of developing type 2 diabetes mellitus in depressed young adults (Brown et al., 2005; Knol et al., 2007) . The mechanism of the association between depression and diabetes is still unknown, although the physiological reaction to the psychological stress associated with diabetes cannot completely explain the association (Grandinetti et al., 2000) . In addition, potential confounding factors that are associated with weight gain and impaired glycemic control, such as body mass index and
